NAD+ and Cellular Energy: The Complete Guide

What You Need to Know

• NAD+ is the coenzyme every cell uses to turn food into ATP and to run its repair enzymes, and in human skin samples from newborns to age 77 it fell steadily with age, with a correlation of r = -0.71 in men (Massudi 2012, PLoS One).
• Oral NMN and NR both raise blood NAD+ in humans within two weeks: NR at 300 mg per day raised whole-blood NAD+ 51% and 1,000 mg raised it 142% over 8 weeks (Conze 2019, Scientific Reports), and NMN at 250 to 900 mg per day raised it in every trial that measured it.
• Plain niacin works too, and it is cheap: 750 to 1,000 mg per day raised blood NAD+ up to 8-fold (Pirinen 2020, Cell Metabolism), at the cost of flushing that NR and NMN do not cause and a liver-monitoring requirement above the 35 mg upper limit.
• Oral NAD+ itself is digested to nicotinamide in the gut before it is absorbed, which has been known since a 1983 rat study (Gross and Henderson, Journal of Nutrition); no capsule should charge you extra for containing the finished molecule.
• Ten weeks of resistance training raised muscle NAD+ 127% in untrained adults averaging 59 years old, a bigger change inside muscle than any supplement trial has reported (Lamb 2020, Aging).
• The response is individual: in the 80-person dose-ranging NMN trial, the rise in blood NAD+ varied by 29% to 113% within each dose group, and 900 mg did no better than 600 mg (Yi 2022, GeroScience; Kuerec 2024, Mechanisms of Ageing and Development).
• No NAD+ precursor has been shown to extend human lifespan. The one rigorous mouse test, the NIA Interventions Testing Program, found nicotinamide riboside did not extend lifespan in either sex (Harrison 2021, Aging Cell).

What is NAD+ and why does it matter?

NAD+ (nicotinamide adenine dinucleotide) is a small molecule present in every living cell, with two jobs that look unrelated until it runs short. The first job is chemistry: NAD+ accepts the electrons stripped from food, becomes NADH, and hands those electrons to the mitochondria, where they drive ATP production. The second job is signaling. Three families of enzymes consume NAD+ as a raw material: the sirtuins (which regulate gene expression and mitochondrial upkeep), the PARPs (which repair broken DNA), and CD38 (an enzyme on immune cells that destroys NAD+ at scale). A cell short on NAD+ makes less energy and repairs less damage at the same time (Covarrubias 2021, Nature Reviews Molecular Cell Biology).

That double role is why the supplement category exists. In rodents, restoring NAD+ with precursors improves a long list of age-related measures, and the researchers who built the field have argued since 2014 that NAD+ decline may be an "Achilles' heel" of aging (Imai and Guarente 2014, Trends in Cell Biology). Whether the same holds in people is the question this guide answers, one section at a time. The short version: the blood chemistry moves, the clinical outcomes mostly have not yet.

Where does NAD+ come from? Mostly from recycling. Cells can build it from scratch out of the amino acid tryptophan, but that happens chiefly in the liver. The bulk of daily NAD+ in muscle, brain, and fat comes from the salvage pathway, which rebuilds NAD+ from nicotinamide, the fragment every sirtuin and PARP reaction leaves behind. The rate-limiting enzyme is NAMPT, which turns nicotinamide into NMN; a second enzyme, NMNAT, turns NMN into NAD+. Nicotinamide riboside (NR) enters one step earlier. Niacin takes a separate route. Isotope tracing in mice showed something marketing rarely mentions: NR and NMN given by mouth were largely converted to nicotinamide in the liver before reaching other tissues, while the same molecules given intravenously arrived intact (Liu 2018, Cell Metabolism). "One step closer to NAD+" is a true statement about a diagram, not about what reaches your muscle.

Go deeper: the NMN monograph draws the salvage pathway out in full and grades the NMN evidence by outcome.

Why does NAD+ fall with age, and by how much?

NAD+ declines with age in human skin, brain, and blood, and so does the muscle enzyme that makes it, but no population "deficiency rate" exists, because no clinical cutoff does. What exists is a set of correlations, all pointing the same way.

In skin samples from 49 people ranging from newborns to age 77, NAD+ content fell with age at r = -0.71 in males and r = -0.54 in females. In the same samples, the DNA-repair enzyme PARP grew more active with age and tracked accumulated DNA damage, which is the likely mechanism: more damage, more PARP activity, more NAD+ burned (Massudi 2012, PLoS One). In living brain, measured by magnetic resonance spectroscopy, NAD+ and the NAD+/NADH ratio fell with age while NADH rose (Zhu 2015, PNAS). In plasma from healthy adults aged 20 to 87, NAD+, NADP, and the intermediate NAAD all declined while nicotinamide and its methylated waste product rose; plasma NMN did not change with age (Clement 2019, Rejuvenation Research).

The supply side weakens too. Across 57 people, muscle NAMPT (the salvage enzyme) correlated negatively with age, and the best predictor of a person's NAMPT level was not their birthday but their VO2peak, a measure of fitness (de Guia 2019, Physiological Reports). Three contributors recur in the reviews: rising CD38 activity on immune cells, PARP activation from accumulated DNA damage, and falling NAMPT. Dietary niacin shortage is not on that list. The RDA is 16 mg niacin equivalents for men and 14 mg for women, most American diets exceed it, and pellagra is rare in the United States (NIH Office of Dietary Supplements).

So the risk factors read as you would expect: age, inactivity (fitness predicts NAMPT), chronic inflammation (which drives CD38), excess body weight (the metabolic trials recruited overweight adults for this reason), and heavy alcohol use, since metabolizing ethanol consumes NAD+. If that reads like the list for everything else, that is the point. NAD+ is a readout of how hard a tissue is worked and how well it is maintained, not a separate problem.

Go deeper: how NAD+ levels decline over time walks the age curve decade by decade.

Can you test your NAD+ level?

Not usefully, as of 2026. Research labs measure whole-blood NAD+ by liquid chromatography with mass spectrometry, which is what every trial on this page used, and consumer mail-in kits that measure a dried blood spot now exist. The problem is not the assay. No reference range defines "low" in a healthy person, no health outcome has been tied to a particular blood value, and blood NAD+ (most of it inside red cells) is not the NAD+ in your muscle or brain. In the one setting where blood testing clearly worked, patients with a rare mitochondrial muscle disorder, blood NAD+ identified the deficiency and tracked muscle NAD+ as niacin corrected it (Pirinen 2020, Cell Metabolism). That is a disease, not aging.

In healthy middle-aged adults the number is noisy. A post-hoc analysis of the 80-person dose-ranging NMN trial found the rise in blood NAD+ varied by 29% to 113% within each dose group, which is why its authors proposed measuring blood NAD+ to personalize dosing (Kuerec 2024, Mechanisms of Ageing and Development). A single baseline reading cannot tell you whether you need a precursor. It can tell you whether one you are already taking is doing anything in your blood, a narrower and more honest use.

What to watch instead: nothing you can feel. Low NAD+ has no symptom of its own. The practical proxies are age and fitness, and the trials themselves used walking distance, grip strength, and insulin sensitivity as their real endpoints. Evidence grade for consumer NAD+ testing as a decision tool: Insufficient.

Go deeper: can NAD+ reverse aging? separates what the molecule can promise from what the marketing does.

Can food, exercise, or fasting raise NAD+ as much as a supplement?

Exercise can, at least inside muscle, and it has better human data than any capsule. Food cannot. Fasting is unproven in people.

Start with food. Meat, fish, peanuts, and fortified grains supply niacin, and the body converts some dietary tryptophan to NAD+ as well, so a normal diet keeps you clear of pellagra. It does not push NAD+ above normal, and no common food contains a meaningful amount of NMN or NR. Some foods contain small amounts of NAD and NADP, which your gut digests to nicotinamide like any other, so there is no "NAD+ diet" beyond eating enough protein (NIH Office of Dietary Supplements).

The surprise: sixteen untrained adults averaging 59 years old did full-body resistance training twice a week for 10 weeks. Muscle NAD+ rose 127%. NADH rose 99%, NAMPT protein 15%, and global sirtuin activity 13%, and where their muscle NAD+ had been lower than that of trained 22-year-olds before the program, afterward the two groups were indistinguishable (Lamb 2020, Aging). A separate 12-week program raised muscle NAMPT 12% to 28% with aerobic work and 25% to 30% with resistance work, in young and older people alike (de Guia 2019). Compare the best muscle data for a supplement: 1 gram of NR per day for 21 days in 12 men in their seventies raised the muscle NAD+ metabolome without changing mitochondrial energy production at all (Elhassan 2019, Cell Reports). The capsule changes the chemistry. The barbell changes the chemistry and the mitochondria.

Caloric restriction has a human study too, though it did not measure NAD+ directly. Thirty-six overweight adults cut calories 25% for six months; muscle SIRT1 expression rose, mitochondrial DNA content rose 35%, and DNA damage fell (Civitarese 2007, PLoS Medicine). Fasting and caloric restriction raise NAD+ in rodent tissues (Covarrubias 2021), but no human trial has measured NAD+ after a fasting protocol, so the honest grade for fasting is Insufficient. Want a lifestyle lever with a number attached? Lift.

Go deeper: raising NAD+ is half of mitochondrial upkeep; clearing worn-out mitochondria is the other half, and Urolithin A is the compound with human data there. You cannot get that one from food either, for a stranger reason.

When does supplementing make sense, and with what?

The decision rule: if you are past 50, training less than you would like, and want the one intervention with a measurable effect in blood, an NMN or NR product at a trial-tested dose is a reasonable 8-to-12-week experiment with a clean safety record. If you are under 40 and active, your muscles are already running the NAMPT program and the trials have nothing to show you. Nobody, at any age, should buy a precursor expecting to live longer; no human evidence supports that, and the best mouse evidence contradicts it.

What the four options actually did in humans:

The NMN trials, in the order they established things. Ten healthy men took single doses of 100, 250, or 500 mg with no adverse effects (Irie 2020, Endocrine Journal). Thirty healthy adults took 250 mg per day for 12 weeks and whole-blood NAD+ rose significantly with no abnormal lab values (Okabe 2022, Frontiers in Nutrition). Older men on 250 mg per day for 6 or 12 weeks showed nominal, not conclusive, gains in gait speed and grip (Igarashi 2022, npj Aging). Twenty-five postmenopausal women with prediabetes took 250 mg per day for 10 weeks, and muscle insulin sensitivity measured by clamp improved in the NMN group only: the most-cited NMN finding, in a small and specific population (Yoshino 2021, Science). Eighty healthy adults aged 40 to 65 took 300, 600, or 900 mg for 60 days. Blood NAD+ rose at every dose and plateaued at 600 mg, six-minute walking distance improved versus placebo, and the NMN manufacturer funded and co-authored the paper (Yi 2022, GeroScience). A pharmaceutical-grade NMN at 1,000 mg once or twice daily for 14 days raised blood NMN 1.7-fold and 3.7-fold in 32 adults aged 55 to 80 (Pencina 2023, Journals of Gerontology A); 28 days at 2,000 mg in 30 overweight adults lowered body weight by 1.9 kg, LDL, and diastolic pressure versus placebo, with no change in strength, aerobic capacity, or insulin sensitivity (Pencina 2023, Journal of Clinical Endocrinology and Metabolism).

Pool those and the picture flattens. A meta-analysis of eight NMN trials in 342 adults found no significant effect on fasting glucose, insulin, HbA1c, insulin resistance, or lipids (Chen 2024, Current Diabetes Reports). Same story for muscle. Pooled NMN and NR trials in adults over 60 showed no effect on muscle mass, grip strength, gait speed, or chair-stand time (Prokopidis 2025, Journal of Cachexia, Sarcopenia and Muscle). Evidence grades by outcome: raising blood NAD+ is Strong; walking distance and physical performance are Preliminary; insulin sensitivity is Preliminary and conflicting; inflammatory markers are Preliminary; lifespan is Insufficient.

The NR trials. Single doses of 100, 300, and 1,000 mg raised the blood NAD+ metabolome dose-dependently, and a rise in the intermediate NAAD turned out to be the most sensitive sign of repletion (Trammell 2016, Nature Communications). Twenty-four adults aged 55 to 79 took 1,000 mg per day for six weeks and NAD+ in blood cells rose about 60% (Martens 2018, Nature Communications). One hundred forty overweight adults took 100, 300, or 1,000 mg for eight weeks; whole-blood NAD+ rose 22%, 51%, and 142% within two weeks and held there, with no flushing and no disruption of methylation metabolism (Conze 2019, Scientific Reports). Forty men with obesity took 2,000 mg per day for 12 weeks and nothing about glucose tolerance or insulin secretion changed (Dollerup 2019, Journal of Clinical Endocrinology and Metabolism). NR is safe at doses far above what anyone sells. Healthier, measurably? Not yet.

And niacin, the precursor your grandmother could buy. Patients with a mitochondrial muscle disorder and their matched controls took niacin titrated to 750 to 1,000 mg per day; blood NAD+ rose up to 8-fold in everyone and strength improved in all subjects (Pirinen 2020). The cost is flushing, which starts at 30 to 50 mg, plus liver-enzyme monitoring at those doses (NIH Office of Dietary Supplements). NR and NMN exist largely because they raise NAD+ without the flush.

Form and timing: every trial above used plain capsules or tablets, once or twice daily, usually in the morning, with or without food. Sublingual and liposomal products have no human comparison data. For NMN, a sealed container kept cool matters more than any delivery gimmick, because the molecule degrades with heat and moisture. Resveratrol and TMG appear in many stacks for mechanistic reasons: resveratrol as a sirtuin activator in cell studies, TMG as a methyl donor to offset nicotinamide clearance. The human NR data at 1,000 mg showed no methylation strain over eight weeks. TMG is insurance, not a requirement.

Go deeper: NMN vs NR, side by side for the head-to-head, and our older take on which precursor reigns supreme, written before the 2022 trials landed.

Which groups should think harder before starting?

Adults over 60 have the most trial data and the least to show for it in function. Blood NAD+ rises reliably; grip, gait, and chair-stand do not, on pooled evidence (Prokopidis 2025). Expect the chemistry, not the strength. Get the strength from the gym.

Active people and athletes: the walking-distance gain in the 60-day trial came from sedentary middle-aged adults, not trained ones (Yi 2022). Already training? Your NAMPT is already up. The marginal gain from a precursor on top of that has never been measured.

People with a cancer history or in active cancer treatment should ask their oncologist before any NAD+ precursor. NAD+ fuels every dividing cell, the rodent data cut both ways, and no human trial has enrolled this group. Here, "it's just a vitamin" is the wrong frame.

People taking prescription niacin, or anyone already above the 35 mg upper limit from a B-complex, should not stack NR or NMN on top without their prescriber in the loop, so the liver monitoring covers the whole stack.

Pregnancy and nursing: no trial has included either group. Skip it until one does.

People who worry about methylation (the "MTHFR" crowd) are asking a fair question: every milligram of precursor eventually leaves as methylated nicotinamide, spending a methyl group. The eight-week NR trial at 1,000 mg measured one-carbon metabolism directly and saw no disruption (Conze 2019). At the doses sold, the concern is theoretical. At megadoses, unstudied.

Go deeper: the NMN, NR, TMG, resveratrol, and zinc stack paper does the methylation accounting in detail and explains why we put 50 mg of TMG in the capsule anyway.

What goes wrong?

Taking too much is wasteful rather than dangerous, within the ranges studied. NMN at 2,000 mg per day for four weeks and NR at 1,000 mg per day for eight weeks produced no more adverse events than placebo (Pencina 2023; Conze 2019), and NR at 2,000 mg per day ran for 12 weeks (Dollerup 2019). But blood NAD+ plateaued between 600 and 900 mg of NMN (Yi 2022), so the second gram buys nothing. There is also a reason not to megadose the cheapest precursor, nicotinamide: at high concentrations it inhibits SIRT1 directly in vitro, the very enzyme people are trying to feed (Bitterman 2002, Journal of Biological Chemistry). Nicotinamide at 3,000 mg per day has caused nausea and signs of liver stress, and nicotinic acid at 1,000 to 3,000 mg per day can impair glucose tolerance and injure the liver, which is why both carry a 35 mg upper limit for unsupervised use (NIH Office of Dietary Supplements).

The wrong product is the bigger risk. NMN is expensive to make and easy to fake; a capsule can contain nicotinamide (pennies), degraded NMN, or nothing. Four things separate a real product from a label: a lot-specific certificate of analysis you can download, not a generic "third-party tested" badge; an NMN assay by HPLC reporting milligrams per serving against the label claim; the beta form (beta-NMN) named, since the alpha form is useless; and heavy metals by ICP-MS on the same lot. No document for the lot in your hand? Assume the worst. Our guide to supplement testing explains how to read one, and our lab-testing page shows what a complete certificate looks like.

Interactions to name for your clinician: alcohol (ethanol metabolism consumes NAD+, and no precursor fixes that); prescription niacin and statins (high-dose niacin carries its own muscle and liver warnings); blood-pressure medication (one NR trial hinted at lower pressure and one NMN trial reported a 7 mmHg diastolic drop, neither established); and diabetes medication (the Yoshino trial moved insulin sensitivity, so watch glucose if you are on drugs that lower it). None of these is a reason to avoid precursors. All are reasons to mention the bottle at your next appointment.

Go deeper: the supplement safety and quality testing guide is the page to read before you trust any label in this category, ours included.

Mt. Angel Vitamins products for NAD+ support

One product fits this topic honestly; two sit next to it.

NMN + NR Cellular Wellness delivers 500 mg of beta-NMN and 200 mg of nicotinamide riboside per two-capsule serving, alongside 250 mg trans-resveratrol, 50 mg TMG, 50 mg BioPerine, and 10 mg zinc as bisglycinate. A bottle holds 30 servings and costs $59.99 as of October 13, 2026: $2.00 per day at the full serving, or $1.00 per day at one capsule (250 mg NMN plus 100 mg NR, which matches the NMN dose used in the Japanese 12-week trials). It supports healthy NAD+ levels and cellular energy production.* We built it with two precursors because the salvage pathway accepts both and the human data cover both; whether two routes beat one in a person has not been tested, and we do not claim it has.

The manufacturing facts, stated once. It is made in our own cGMP facility in Mt. Angel, Oregon. Every batch is tested in our in-house lab for identity, potency, and purity. The certificate of analysis for each lot is published at our lab-testing page. The current lot tested at 614 mg NMN per serving by HPLC against a 500 mg claim, confirmed independently by an ISO-accredited outside laboratory.

If you want NR alone with the longest trial history, Tru Niagen (ChromaDex) is the product most of the NR trials above used, and we sell nothing like it. Want plain 250 mg NMN at the lowest cost? Several brands undercut us; what you give up is the lot certificate.

Two related ingredients, each with its own monograph. Urolithin A works on the other side of mitochondrial upkeep, clearing worn-out mitochondria; our Urolithin A 500 mg is one capsule daily, 60 servings, $89.99, or $1.50 per day, and supports mitochondrial renewal.* CoQ10 carries electrons inside the mitochondria that NAD+ feeds; our CoQ10 + Alpha Lipoic Acid 100 mg is one capsule daily, 60 capsules, $25.99, or $0.43 per day, and supports cellular energy production.* Neither raises NAD+. Do not buy either for that.

Go deeper: the NAD+ stack visualized shows our modeled case for the five-ingredient capsule, labeled as modeled, not measured.

The bottom line

Take an NMN or NR product at a trial dose (250 to 600 mg NMN, or 300 to 1,000 mg NR) if you are over 50, want a measurable change in blood NAD+, and accept that the functional benefits remain preliminary. Lift weights twice a week regardless; that is the intervention with the best human NAD+ data on this page. Skip anything sold as oral "NAD+" itself, skip IV drips, and skip the whole category if you are pregnant, in cancer treatment, or on prescription niacin, until you have had the conversation.

Keep reading

• NMN monograph: every NMN trial graded by outcome, plus dosing and safety.
• NMN vs NR compared: evidence, dose, and cost per day, head to head.
• The five-ingredient NAD+ stack paper: why we combined NMN, NR, TMG, resveratrol, and zinc.
• The NAD+ stack, visualized: modeled charts of retention and bottlenecks.
• Urolithin A monograph: mitophagy, and why most people cannot make it from pomegranate.
• CoQ10 monograph: the electron carrier downstream of NAD+.
• Urolithin A and mitochondrial quality control: the clearance side of the equation.
• Best Urolithin A supplements: our ranked guide; we gave ourselves one of five picks.
• Lab testing and certificates of analysis: every lot we have released, with the numbers.
• NAD+ and life expectancy: the longevity question in plain language.
• The complete guide to vitamin D: the nutrient most adults over 50 are actually short on, with a real test.
• Immune health: where CD38, the biggest NAD+ consumer in aging, does its work.

Sources

1. Covarrubias AJ, et al. NAD+ metabolism and its roles in cellular processes during ageing. Nat Rev Mol Cell Biol. 2021. PubMed 33353981
2. Imai S, Guarente L. NAD+ and sirtuins in aging and disease. Trends Cell Biol. 2014. PubMed 24786309
3. Liu L, et al. Quantitative analysis of NAD synthesis-breakdown fluxes. Cell Metab. 2018. PubMed 29685734
4. Massudi H, et al. Age-associated changes in oxidative stress and NAD+ metabolism in human tissue. PLoS One. 2012. PubMed 22848760
5. Zhu XH, et al. In vivo NAD assay reveals the intracellular NAD contents and redox state in healthy human brain and their age dependences. Proc Natl Acad Sci U S A. 2015. PubMed 25730862
6. Clement J, et al. The plasma NAD+ metabolome is dysregulated in "normal" aging. Rejuvenation Res. 2019. PubMed 30124109
7. de Guia RM, et al. Aerobic and resistance exercise training reverses age-dependent decline in NAD+ salvage capacity in human skeletal muscle. Physiol Rep. 2019. PubMed 31207144
8. Pirinen E, et al. Niacin cures systemic NAD+ deficiency and improves muscle performance in adult-onset mitochondrial myopathy. Cell Metab. 2020. PubMed 32386566
9. Kuerec AH, et al. Towards personalized nicotinamide mononucleotide (NMN) supplementation: nicotinamide adenine dinucleotide (NAD) concentration. Mech Ageing Dev. 2024. PubMed 38430946
10. Lamb DA, et al. Resistance training increases muscle NAD+ and NADH concentrations as well as NAMPT protein levels and global sirtuin activity in middle-aged, overweight, untrained individuals. Aging (Albany NY). 2020. PubMed 32369778
11. Elhassan YS, et al. Nicotinamide riboside augments the aged human skeletal muscle NAD+ metabolome and induces transcriptomic and anti-inflammatory signatures. Cell Rep. 2019. PubMed 31412242
12. Civitarese AE, et al. Calorie restriction increases muscle mitochondrial biogenesis in healthy humans. PLoS Med. 2007. PubMed 17341128
13. Irie J, et al. Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men. Endocr J. 2020. PubMed 31685720
14. Okabe K, et al. Oral administration of nicotinamide mononucleotide is safe and efficiently increases blood nicotinamide adenine dinucleotide levels in healthy subjects. Front Nutr. 2022. PubMed 35479740
15. Igarashi M, et al. Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men. NPJ Aging. 2022. PubMed 35927255
16. Yoshino M, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. 2021. PubMed 33888596
17. Yi L, et al. The efficacy and safety of beta-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial. GeroScience. 2022. PubMed 36482258
18. Pencina KM, et al. MIB-626, an oral formulation of a microcrystalline unique polymorph of beta-nicotinamide mononucleotide, increases circulating nicotinamide adenine dinucleotide and its metabolome in middle-aged and older adults. J Gerontol A Biol Sci Med Sci. 2023. PubMed 35182418
19. Pencina KM, et al. Nicotinamide adenine dinucleotide augmentation in overweight or obese middle-aged and older adults: a physiologic study. J Clin Endocrinol Metab. 2023. PubMed 36740954
20. Chen F, et al. Effects of nicotinamide mononucleotide on glucose and lipid metabolism in adults: a systematic review and meta-analysis of randomised controlled trials. Curr Diab Rep. 2024. PubMed 39531138
21. Prokopidis K, et al. The effect of nicotinamide mononucleotide and riboside on skeletal muscle mass and function: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2025. PubMed 40275690
22. Trammell SA, et al. Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Nat Commun. 2016. PubMed 27721479
23. Martens CR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nat Commun. 2018. PubMed 29599478
24. Conze D, et al. Safety and metabolism of long-term administration of NIAGEN (nicotinamide riboside chloride) in a randomized, double-blind, placebo-controlled clinical trial of healthy overweight adults. Sci Rep. 2019. PubMed 31278280
25. Dollerup OL, et al. Effects of nicotinamide riboside on endocrine pancreatic function and incretin hormones in nondiabetic men with obesity. J Clin Endocrinol Metab. 2019. PubMed 31390002
26. Bitterman KJ, et al. Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast Sir2 and human SIRT1. J Biol Chem. 2002. PubMed 12297502
27. Gross CJ, Henderson LM. Digestion and absorption of NAD by the small intestine of the rat. J Nutr. 1983. PubMed 6218262
28. Grant R, et al. A pilot study investigating changes in the human plasma and urine NAD+ metabolome during a 6 hour intravenous infusion of NAD+. Front Aging Neurosci. 2019. PubMed 31572171
29. Mills KF, et al. Long-term administration of nicotinamide mononucleotide mitigates age-associated physiological decline in mice. Cell Metab. 2016. PubMed 28068222
30. Zhang H, et al. NAD+ repletion improves mitochondrial and stem cell function and enhances life span in mice. Science. 2016. PubMed 27127236
31. Harrison DE, et al. 17-a-estradiol late in life extends lifespan in aging UM-HET3 male mice; nicotinamide riboside and three other drugs do not affect lifespan in either sex. Aging Cell. 2021. PubMed 33788371
32. National Institutes of Health, Office of Dietary Supplements. Niacin fact sheet for health professionals. ods.od.nih.gov

Common Myths

"NAD+ pills reverse aging."

They do not, and nobody has tested whether they could. The study behind the phrase gave mice NMN for 12 months and reported that it "mitigated" age-related decline in weight gain, energy expenditure, and eye function; it did not measure lifespan, and the word "reverse" appears nowhere in it (Mills 2016, Cell Metabolism). The human trials run 10 weeks to a year and measure blood chemistry and walking distance. The one that reported "biological age" used a blood-chemistry algorithm, not a clock anyone has validated against actual aging (Yi 2022). When the NIA's Interventions Testing Program, the gold standard for mouse lifespan work, fed nicotinamide riboside to genetically diverse mice, lifespan did not change in either sex (Harrison 2021, Aging Cell). Raising NAD+ is real. Reversing anything is a slogan.

"More is better."

Blood NAD+ plateaued between 600 and 900 mg of NMN in the only dose-ranging trial, so the extra 300 mg bought nothing (Yi 2022). Above the plateau the surplus is methylated and sent out in urine, spending a methyl group on the way. Megadosing the cheapest precursor, nicotinamide, is worse than wasteful: at high concentrations it directly inhibits SIRT1, the enzyme the whole exercise is supposed to feed (Bitterman 2002, Journal of Biological Chemistry). And nicotinic acid past the 35 mg upper limit flushes, past 1,000 mg it can impair glucose tolerance and injure the liver (NIH Office of Dietary Supplements). The trial doses, 250 to 600 mg NMN or 300 to 1,000 mg NR, are the useful range. Everything above is a donation to your toilet.

"NMN is one step closer to NAD+, so it beats NR."

On the whiteboard, yes. In a mouse with isotope-labeled precursors, oral NMN and oral NR were both broken down to nicotinamide in the liver before reaching other tissues, which means most of what arrives in muscle arrives the same way whichever you swallowed (Liu 2018, Cell Metabolism). NR at 1,000 mg raised whole-blood NAD+ 142% in eight weeks (Conze 2019); NMN trials report rises of similar scale but have never been run head to head against NR in the same people at matched doses. "One step closer" sells capsules. It has not won a trial.

"If my blood NAD+ went up, I'm younger."

Blood NAD+ is a reading from red cells, not from the tissues you care about. In 12 men in their seventies, three weeks of 1 gram NR raised the muscle NAD+ metabolome and changed nothing about mitochondrial energy production (Elhassan 2019, Cell Reports). Pooled across every NMN and NR trial in adults over 60, muscle mass, grip, gait speed, and chair-stand time did not improve (Prokopidis 2025). The number moved. The person, so far, did not.

"IV NAD+ drips work better than capsules."

This is the one that costs the most, so it goes last. In the only published human study of an NAD+ infusion, volunteers received NAD+ intravenously for six hours; for the first two hours, plasma NAD+ did not rise at all, because the molecule was being removed from the blood as fast as it arrived. The metabolites that appeared were the signature of NAD+ being broken apart, and the urine collected afterward contained NAD+ and methylated nicotinamide, meaning a meaningful share of the drip left the body unused (Grant 2019, Frontiers in Aging Neuroscience). Two of the authors are affiliated with an IV NAD+ clinic, so this is not a hostile read. A drip is billed by the session and requires a needle, a chair, and an afternoon. A 300 mg NR capsule raised whole-blood NAD+ 51% for well under two dollars a day (Conze 2019). The oral route is slower, cheaper, and has more than a dozen trials behind it. The IV route has one pilot study and a waiting room.

Mt. Angel Vitamins for NAD+ and Cellular Energy: The Complete Guide

• NMN + NR Cellular Wellness Supplement – Support Healthy NAD+ Levels, Mitochondrial Health & Longevity – with Resveratrol, TMG, BioPerine® & Zinc – 60 Capsules

  $59.99

  Shop Now

Frequently Asked Questions

What is NAD+ and why does it decline with age?

NAD+ (nicotinamide adenine dinucleotide) is the coenzyme every cell uses to move electrons from food into ATP and to run its repair enzymes, the sirtuins and PARPs. It falls with age because consumption rises (the immune enzyme CD38 and DNA-repair PARPs burn more of it) while the recycling enzyme NAMPT declines. In human skin samples from newborns to age 77, NAD+ fell with age at r = -0.71 in men (Massudi 2012), and brain NAD+ measured by MR spectroscopy fell the same way (Zhu 2015). There is no population deficiency rate, because no clinical cutoff for low NAD+ exists.

NMN vs NR vs niacin vs NAD+ itself: what actually raises NAD+ in humans?

NMN, NR, and niacin all raise blood NAD+ in humans; oral NAD+ itself does not survive digestion. NR at 100, 300, and 1,000 mg per day raised whole-blood NAD+ 22%, 51%, and 142% within two weeks (Conze 2019). NMN at 250 to 900 mg per day raised it in every trial that measured it (Okabe 2022, Yi 2022). Niacin at 750 to 1,000 mg raised it up to 8-fold but flushes and needs liver monitoring (Pirinen 2020). Oral NAD+ is cleaved to nicotinamide in the gut (Gross 1983). Our [NMN vs NR comparison](/compare/nmn-vs-nicotinamide-riboside) goes head to head on dose, cost, and evidence.

What did the human trials of NAD+ precursors measure, and what changed?

They measured blood NAD+ first, and that rose every time. Beyond that: six-minute walking distance improved on 300 to 900 mg NMN in sedentary adults aged 40 to 65 (Yi 2022); muscle insulin sensitivity improved on 250 mg NMN in 25 postmenopausal women with prediabetes (Yoshino 2021); inflammatory cytokines fell on 1 g NR in older men (Elhassan 2019); and body weight and LDL fell on 2 g NMN over 28 days (Pencina 2023). Pooled across trials, glucose, lipids, muscle mass, and strength did not change significantly (Chen 2024; Prokopidis 2025). The chemistry moved reliably; the function moved in single trials only.

Do sirtuins matter for the average person?

Yes, but not as something you can buy. Sirtuins are seven NAD+-dependent enzymes that regulate mitochondrial upkeep, DNA repair, and gene silencing, and their activity tracks NAD+ availability. The clearest human evidence that you can raise sirtuin activity comes from the gym: 10 weeks of resistance training raised global sirtuin activity 13% alongside a 127% rise in muscle NAD+ in untrained adults around 59 (Lamb 2020). Six months of 25% caloric restriction raised muscle SIRT1 expression (Civitarese 2007). No supplement trial has shown a sirtuin-driven outcome in a healthy person, and high-dose nicotinamide inhibits SIRT1 in vitro (Bitterman 2002).

Does exercise or fasting raise NAD+ as much as a supplement?

Exercise raises it more, at least in muscle. Ten weeks of twice-weekly resistance training raised muscle NAD+ 127% and NAMPT 15% in 16 untrained adults averaging 59 years old, bringing them level with trained 22-year-olds (Lamb 2020); 12 weeks of aerobic or resistance training raised muscle NAMPT 12% to 30% (de Guia 2019). The best supplement muscle data, 1 g NR for 21 days, raised the muscle NAD+ metabolome without changing mitochondrial function (Elhassan 2019). Fasting raises NAD+ in rodents, but no human trial has measured NAD+ after a fasting protocol, so that claim is unproven in people.

What dose ranges did the trials use?

NMN: single doses of 100 to 500 mg (Irie 2020); 250 mg per day for 6 to 12 weeks (Okabe 2022, Igarashi 2022, Yoshino 2021); 300, 600, or 900 mg per day for 60 days, with blood NAD+ plateauing at 600 mg (Yi 2022); and 1,000 to 2,000 mg per day for 2 to 4 weeks (Pencina 2023). NR: 100 to 1,000 mg per day for 8 weeks (Conze 2019) and 2,000 mg per day for 12 weeks (Dollerup 2019). Niacin: 750 to 1,000 mg per day under supervision (Pirinen 2020). The useful consumer range is 250 to 600 mg NMN or 300 to 1,000 mg NR; the [NMN monograph](/ingredients/nmn-nicotinamide-mononucleotide) has the detail.

Is there any evidence NAD+ precursors extend human lifespan?

No. None. No human trial of NMN, NR, or niacin has measured lifespan, and none could; the longest ran about a year. The mouse evidence is mixed and mostly negative: one study reported a modest lifespan extension with NR started late in life (Zhang 2016), the 12-month NMN study measured healthspan markers and not lifespan at all (Mills 2016), and the NIA Interventions Testing Program, which uses genetically diverse mice at three sites, found NR did not extend lifespan in either sex (Harrison 2021). Anyone who tells you a precursor will make you live longer is extrapolating from a diagram. We sell one and we will not tell you that.

Are NAD+ IV drips worth it?

Probably not. The only published human study infused NAD+ for six hours; plasma NAD+ did not rise for the first two hours because the molecule was being cleared as fast as it arrived, the metabolites that showed up were breakdown products, and the urine afterward contained unused NAD+ and methylated nicotinamide (Grant 2019). Two of that paper's authors are affiliated with an IV NAD+ clinic. An oral 300 mg NR capsule raised whole-blood NAD+ 51% over eight weeks (Conze 2019) for a fraction of the cost of one infusion. If you want the blood number up, the capsule does it. If you want an afternoon in a recliner, the drip does that.

Who should avoid NAD+ precursors?

Anyone pregnant or nursing (no trial has included them); anyone with a cancer history or in active cancer treatment, until their oncologist weighs in, because NAD+ fuels every dividing cell and the rodent data cut both ways; and anyone already taking prescription niacin above the 35 mg upper limit, who should not stack more precursors without their prescriber. People on blood-pressure or diabetes medication can usually take them but should mention it, since single trials have reported lower diastolic pressure (Pencina 2023) and better insulin sensitivity (Yoshino 2021). At the doses sold, side effects in the trials matched placebo.

How do you tell a legitimate NMN product from a fake?

Ask for the lot-specific certificate of analysis and read four lines. One: an NMN assay by HPLC reporting milligrams per serving against the label claim, ideally confirmed by an outside ISO-accredited lab. Two: the form named as beta-NMN, since the alpha isomer is inactive. Three: heavy metals by ICP-MS on the same lot. Four: a lot number that matches the bottle in your hand, not a generic "third-party tested" badge. NMN is expensive to make and nicotinamide costs pennies, so a brand that cannot produce that document has given you your answer. Our [lab-testing page](/reviews/lab-testing) shows what a complete certificate looks like.

Deep Dives

• Best NMN + NR Supplements in the US (2026 Buyer's Guide) — We compared nine NAD+ precursor products sold in the US, verified on each brand's own site on October 13, 2026, against six criteria: dose versus the human trials, lot-level testing, form, cost per day, fillers, and serving honesty. Seven made the ranking. Tru Niagen wins on clinical history for NR alone. For a combined NMN + NR capsule with a public lot certificate, our own product takes the top spot, and the math is shown rather than asserted.
• The Synergistic NAD⁺ Stack: Interactive Data Visualizations — Interactive data visualizations comparing NAD⁺ bioavailability across monotherapy vs. the synergistic stack protocol. Charts cover 90-day NAD⁺ retention, telomere trajectory modeling, pathway bottleneck analysis, and the five-ingredient ecosystem approach.
• Synergistic Modulation of the NAD⁺ Metabolome and Telomere Dynamics: NMN, NR, TMG, Resveratrol, and Zinc Co-Supplementation — A comprehensive analysis of why isolated NMN or NR supplementation hits biological bottlenecks, and how co-administering NMN, NR, TMG, resveratrol, and zinc creates a synergistic protocol that maximizes NAD⁺ bioavailability, prevents methylation drain, activates sirtuin longevity enzymes, and protects telomere architecture. Covers pharmacokinetics, the NNMT methylation sink, SIRT1/SIRT6 zinc-dependent mechanisms, resveratrol-driven tissue redistribution, and the hTERT telomerase activation pathway.